This website uses cookies
Read our Privacy policy and Terms of use for more information.
Oct 21, 2026
•
4 min read
Your biggest churn window opens a lot earlier.
Oct 14, 2026
Plus the Black Friday work that has to start now.
Oct 7, 2026
3 min read
The letter reached past the pharmacy into intake.
Sep 30, 2026
A Yale review shows exactly what that backstop caught.
Sep 23, 2026
Which patients can leave for a copay, and what to send
Sep 16, 2026
One field decides if the refill text ever sends.
Sep 9, 2026
There is a threshold, and a price per dispute.
Sep 2, 2026
Your highest-open messages aren't in your ESP.
Aug 26, 2026
And your refill flow has no in-person step in it.
Aug 19, 2026
Revenue per patient rose. Gross profit didn't.
Aug 12, 2026
And it answers before your day 14 check-in does.
Aug 5, 2026
The FTC just put a price on your cancel button.
Jul 29, 2026
The next gold rush is here. Retention decides it.
Jul 22, 2026
And the patients on it are your next churn risk.
Jul 15, 2026
Your contact list may have crossed the line.
Jul 8, 2026
They return to whoever’s in front of them.
Jul 1, 2026
Cheaper access means lower-commitment patients
Jun 24, 2026
The cheaper growth play is already on your list.
Jun 17, 2026
The price-jump play if/when patients switch to branded.
Jun 10, 2026
The $1.15B reason Hims' CAC math beats yours.
Jun 3, 2026
What it means when meds become the cheap part...
May 27, 2026
Most telehealth lifecycles end at goal weight, and that’s the retention cliff.
May 20, 2026
The Hims and Ro duopoly is now competing on price. For private telehealth brands, plan length is the retention lever most aren't using.
May 13, 2026
5 min read
Novo’s Q1 print confirms the oral GLP-1 cohort is real and growing fast
May 6, 2026
The cash-pay GLP-1 cohort to identify now and the patient experience that protects them.
